Skip to main content

RETRACTION article

Front. Oncol., 15 January 2021
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.644690

Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA

This article is a retraction of:

  1. RETRACTED: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original Research article
    The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA

    by Zhang L, Deng Y, Zhang Y, Liu C, Zhang S, Zhu W, Tang Y and Deng N (2020). Front. Oncol. 10:1190. doi: 10.3389/fonc.2020.01190

    Following publication, concerns were raised regarding the integrity of Figures 3B and 3D. An investigation was conducted in accordance with Frontiers guidelines and the authors failed to provide a satisfactory explanation.

    This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers.

    Keywords:

    Citation: Frontiers Editorial Office (2021) Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA. Front. Oncol. 10:644690. doi: 10.3389/fonc.2020.644690

    Received: 21 December 2020; Accepted: 21 December 2020;
    Published: 15 January 2021.

    Approved by: Giuseppe Giaccone, Cornell University, United States

    Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.